Sort   by:  
 Page size 
UnknownResults of PD-L1 Analysis of Women Treated with Durvalumab in Advanced Endometrial Carcinoma (PHAEDRA).
Not available
S-EPMC9818816 | biostudies-literature
UnknownA dynamic inflammatory cytokine network in the human ovarian cancer microenvironment.
Not available
S-EPMC3252703 | biostudies-literature
UnknownEfficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma.
Not available
S-EPMC10582968 | biostudies-literature
UnknownClinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial.
Not available
S-EPMC8190057 | biostudies-literature
UnknownGenetic Predictors of Depressive Symptoms in the Look AHEAD Trial.
Not available
S-EPMC4643359 | biostudies-literature
UnknownCopy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.
Not available
S-EPMC9949586 | biostudies-literature
UnknownObesity susceptibility loci and dietary intake in the Look AHEAD Trial.
Not available
S-EPMC3349457 | biostudies-literature
UnknownHuman cardiovascular disease IBC chip-wide association with weight loss and weight regain in the look AHEAD trial.
Not available
S-EPMC4257841 | biostudies-literature
UnknownAssociation of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trial.
Not available
S-EPMC3406235 | biostudies-literature
Sort   by:  
 Page size